Parallax Volatility Advisers, L.P. Incyte Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $1.43 Million - $1.71 Million	24,900 New	24,900 $1.65 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $576,810 - $679,218	10,200 New	10,200 $581,000
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $2.36 Million - $2.89 Million	-33,600 Reduced 87.05%	5,000 $361,000
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $2.55 Million - $3.2 Million	38,600 New	38,600 $2.57 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $662,068 - $801,140	8,200 Added 1025.0%	9,000 $783,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $8.55 Million - $11.6 Million	-135,400 Reduced 99.41%	800 $59,000
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $9.82 Million - $12.9 Million	134,400 Added 7466.67%	136,200 $11.9 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $131,076 - $155,736	1,800 New	1,800 $0
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $3.18 Million - $4.41 Million	-50,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $926,250 - $1.11 Million	-15,000 Reduced 23.08%	50,000 $3.45 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $3.41 Million - $4.7 Million	56,000 Added 622.22%	65,000 $4.36 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $4.15 Million - $5.05 Million	-50,000 Reduced 84.75%	9,000 $750,000
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $5.52 Million - $6.88 Million	59,000	59,000 $5.59 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.